GEORGE M. JENKINS - 18 Dec 2024 Form 4 Insider Report for PALVELLA THERAPEUTICS, INC. (PVLA)

Role: Director
Signature: Kathleen A. McGowan, Attorney-in-Fact
Issuer symbol: PVLA
Transactions as of: 18 Dec 2024
Net transactions value: +$51,720
Form type: 4
Filing time: 19 Dec 2024, 10:23:28 UTC
Previous filing: 17 Dec 2024
Next filing: 10 Apr 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PVLA	Common Stock	Purchase	$51,720	+4,000	+2.3%	$12.93	180,671	18 Dec 2024	Direct	F1
holding	PVLA	Common Stock						11,026	18 Dec 2024	by Eagles Mere Air Museum Foundation

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.59 to $13.09, inclusive. The reporting person undertakes to provide to Palvella Therapeutics, Inc., any security holder of Palvella Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.59 to $13.09, inclusive. The reporting person undertakes to provide to Palvella Therapeutics, Inc., any security holder of Palvella Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.